Dr. John Hixson Brings Clinical Neurology Expertise To FreshBlood

Hixson Named Sr. Medical Director/Neurologist for FreshBlood’s Consortium

San Francisco, CA, Jan 13, 2016 — FreshBlood Health Market Consultants, a
unique, on-demand creative consultancy comprised of senior-level management
consultants and communications specialists in the healthcare industry, has
continued to expand its clinical capabilities and scientific expertise with
the addition of highly regarded neurologist, John Hixson, MD. Dr. Hixson
will step into a prominent role as a Senior Medical Director / Neurologist
for the FreshBlood consortium, and is already actively aiding the company in
current scientific advisory assignments.

Dr. Hixson is an accomplished clinical neurologist, associate professor at
the University of California San Francisco, American Academy of Neurology
Committee member, published author, and public speaker who holds a degree
from the Johns Hopkins University School of Medicine and completed his
residency at the Hospital of the University of Pennsylvania.

“It is absolutely vital to FreshBlood’s success that I bring in physicians
with elite academic credentials and professional experience. Dr. Hixson
exemplifies our offering, providing scientific expertise in an advisory role
that is invaluable to myself and to FreshBlood’s clients,” said FreshBlood
CEO Robert Finkel. “We are honored to have him.”

While maintaining his clinical practice as an epileptologist at the San
Francisco VA Medical Center, Dr. Hixson also actively conducts pioneering
digital health research across the UCSF community. He is primarily focused
on academically evaluating digital monitoring technologies and devices for
seizure detection and quantification.

Working on the frontline of e-health technology and healthcare policy, Dr.
Hixson also serves as the Deputy Associate Chief of Staff for Clinical
Informatics at the SF VA Medical Center. Additionally, he previously served
as a clinical lead for patient-facing technologies in the VHA Health
Informatics Initiative (hi2) based in Washington DC.

“FreshBlood’s concept stands alone in the field of biopharma marketing and
piqued my interest, in that I would be able to collaborate with other top
minds in the industry on a wide variety of priojects,” said Dr. John Hixson.
“The projects I’ve already provided input on have proven to be extremely
worthwhile and I look forward to functioning as one of FreshBlood’s many
contributing arteries.”

About FreshBlood

FreshBlood is a unique creative consultancy headed by former agency
principal and global creative director, Robert Finkel – one of the
healthcare industry’s most respected and award-winning marketers.
FreshBlood’s consortium of health market experts includes health industry
executives, select physicians, and top-tier creative talent. The creative
consultancy’s primary focus is emerging biopharma and medical device
companies that need innovative thinking, deep expertise, and senior-level
experience. The FreshBlood team has a rich, collective history of building
and sustaining successful brands and commercial franchises within the
healthcare sector. www.freshblood.com